235 related articles for article (PubMed ID: 22555026)
1. Evaluation of mast cell activation syndromes: impact of pathology and immunohistology.
Horny HP; Sotlar K; Valent P
Int Arch Allergy Immunol; 2012; 159(1):1-5. PubMed ID: 22555026
[TBL] [Abstract][Full Text] [Related]
2. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
Picard M; Giavina-Bianchi P; Mezzano V; Castells M
Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
[TBL] [Abstract][Full Text] [Related]
3. Mast cell activation syndromes: definition and classification.
Valent P
Allergy; 2013 Apr; 68(4):417-24. PubMed ID: 23409940
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261124
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.
Muñoz-González JI; García-Montero AC; Orfao A; Álvarez-Twose I
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):427-434. PubMed ID: 34298172
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.
Arock M; Valent P
Expert Rev Hematol; 2010 Aug; 3(4):497-516. PubMed ID: 21083038
[TBL] [Abstract][Full Text] [Related]
8. A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders.
Romantowski J; Górska A; Niedoszytko M; Gulen T; Gruchała-Niedoszytko M; Nedoszytko B; Lange M; Brockow K; Arock M; Akin C; Valent P
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535634
[TBL] [Abstract][Full Text] [Related]
9. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
Zaghmout T; Maclachlan L; Bedi N; Gülen T
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
[TBL] [Abstract][Full Text] [Related]
10. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
Jennings S; Russell N; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
J Allergy Clin Immunol Pract; 2014; 2(1):70-6. PubMed ID: 24565772
[TBL] [Abstract][Full Text] [Related]
11. Mast cell activation syndromes presenting as anaphylaxis.
Akin C
Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
13. Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.
Valent P; Akin C; Bonadonna P; Hartmann K; Brockow K; Niedoszytko M; Nedoszytko B; Siebenhaar F; Sperr WR; Oude Elberink JNG; Butterfield JH; Alvarez-Twose I; Sotlar K; Reiter A; Kluin-Nelemans HC; Hermine O; Gotlib J; Broesby-Olsen S; Orfao A; Horny HP; Triggiani M; Arock M; Schwartz LB; Metcalfe DD
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1125-1133.e1. PubMed ID: 30737190
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis, progression patterns and prognostication in mastocytosis.
Sperr WR; Valent P
Expert Rev Hematol; 2012 Jun; 5(3):261-74. PubMed ID: 22780207
[TBL] [Abstract][Full Text] [Related]
15. Mastocytosis.
Metcalfe DD
Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells.
Horny HP
Am J Clin Pathol; 2009 Sep; 132(3):438-47. PubMed ID: 19687320
[TBL] [Abstract][Full Text] [Related]
17. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
Horny HP; Ruck P; Kröber S; Kaiserling E
Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
[TBL] [Abstract][Full Text] [Related]
18. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.
Valent P; Akin C; Arock M; Brockow K; Butterfield JH; Carter MC; Castells M; Escribano L; Hartmann K; Lieberman P; Nedoszytko B; Orfao A; Schwartz LB; Sotlar K; Sperr WR; Triggiani M; Valenta R; Horny HP; Metcalfe DD
Int Arch Allergy Immunol; 2012; 157(3):215-25. PubMed ID: 22041891
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
20. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
